Recursion Pharmaceuticals (RXRX) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.52
-0.42
-0.32
-0.22

Details

Expected EPS
-0.265
Actual EPS
-0.22
Surprise EPS
0.05
Surprise Percent
+16.98%

Description

⁨Recursion Pharmaceuticals⁩ (⁦RXRX⁩) has reported earnings of ⁦-0.22⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts